• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Septic Shock Secondary to a Urinary Tract Infection with Pediococcus Pentosaceus.由戊糖片球菌引起的尿路感染继发的脓毒性休克
Mo Med. 2016 May-Jun;113(3):179-81.
2
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.哌拉西林/他唑巴坦与替卡西林/克拉维酸治疗细菌感染的随机对照临床试验
Chin Med J (Engl). 1998 Nov;111(11):1039-43.
3
An unusual case of septic shock in a geriatric patient.一名老年患者发生的罕见脓毒症休克病例。
Conn Med. 2010 Mar;74(3):133-7.
4
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.厄他培南与哌拉西林/他唑巴坦治疗复杂性腹腔内感染：一项双盲、随机对照III期试验的结果
Ann Surg. 2003 Feb;237(2):235-45. doi: 10.1097/01.SLA.0000048551.32606.73.
5
Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.产超广谱β-内酰胺酶肠杆菌科导致的尿路感染的非碳青霉烯类治疗。
Med Mal Infect. 2015 May;45(5):169-72. doi: 10.1016/j.medmal.2015.03.003. Epub 2015 Apr 4.
6
Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.产超广谱β-内酰胺酶（ESBL）和Amp-Cβ-内酰胺酶的情况以及复杂尿路感染对新型抗菌药物的敏感性
Indian J Med Res. 2008 Jan;127(1):85-8.
7
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.牛抗菌肽吲哚杀菌素与哌拉西林/他唑巴坦联用在大鼠多菌性腹膜炎实验模型中的疗效
Crit Care Med. 2008 Jan;36(1):240-5. doi: 10.1097/01.CCM.0000292157.60632.89.
8
Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen.戊糖片球菌引起的败血症：一种新的机会致病菌。
J Infect. 1991 Sep;23(2):179-82. doi: 10.1016/0163-4453(91)92190-g.
9
Piperacillin/tazobactam in treatment of brain abscess.哌拉西林/他唑巴坦治疗脑脓肿
Scand J Infect Dis. 2006;38(3):224-6. doi: 10.1080/00365540500348978.
10
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.哌拉西林-他唑巴坦对产超广谱β-内酰胺酶大肠埃希菌和克雷伯菌属的CLSI药敏折点的临床相关性
Antimicrob Agents Chemother. 2006 Jun;50(6):2244-7. doi: 10.1128/AAC.00381-05.

引用本文的文献

1
Pediococcus pentosaceus Endocarditis in a Patient With Recent Transcatheter Aortic Valve Implantation and Liver Cirrhosis: A Case Report and Review of the Literature.近期行经导管主动脉瓣植入术及肝硬化患者的戊糖片球菌性心内膜炎：病例报告及文献复习
Cureus. 2024 Apr 3;16(4):e57509. doi: 10.7759/cureus.57509. eCollection 2024 Apr.
2
Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?哌拉西林-他唑巴坦对于澳大利亚不明原因的医院获得性脓毒症和社区获得性感染性休克来说是一种合适的经验性用药吗？
Healthcare (Basel). 2022 May 5;10(5):851. doi: 10.3390/healthcare10050851.
3
Scientific Opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA (2017-2019).关于向欧洲食品安全局通报的（2017 - 2019年）有意添加到食品或饲料中的QPS推荐生物制剂清单更新的科学意见。
EFSA J. 2020 Feb 3;18(2):e05966. doi: 10.2903/j.efsa.2020.5966. eCollection 2020 Feb.
4
Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 7: suitability of taxonomic units notified to EFSA until September 2017.向欧洲食品安全局（EFSA）通报的有意添加到食品或饲料中的QPS推荐生物制剂清单更新7：截至2017年9月向EFSA通报的分类单元的适用性。
EFSA J. 2018 Jan 24;16(1):e05131. doi: 10.2903/j.efsa.2018.5131. eCollection 2018 Jan.

本文引用的文献

1
Resolution of persistent Pediococcus bacteremia with daptomycin treatment: case report and review of the literature.万古霉素治疗肠球菌血症的疗效：病例报告及文献复习。
Diagn Microbiol Infect Dis. 2010 Jan;66(1):111-5. doi: 10.1016/j.diagmicrobio.2008.10.003. Epub 2008 Dec 10.
2
Phenotypic and genotypic characterization of Pediococcus strains isolated from human clinical sources.从人类临床样本中分离出的片球菌菌株的表型和基因型特征
J Clin Microbiol. 2001 Apr;39(4):1241-6. doi: 10.1128/JCM.39.4.1241-1246.2001.
3
Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020.片球菌属的抗菌药敏性及嗜酸片球菌HM3020中大环内酯抗性的遗传基础。
Antimicrob Agents Chemother. 1993 Apr;37(4):789-92. doi: 10.1128/AAC.37.4.789.
4
Pediococcus pentosaceus catheter-associated infection in an infant with gastroschisis.一名患有腹裂的婴儿发生戊糖片球菌导管相关感染。
Pediatr Infect Dis J. 1994 Jan;13(1):75-6.
5
Septicaemia caused by Pediococcus pentosaceus: a new opportunistic pathogen.戊糖片球菌引起的败血症：一种新的机会致病菌。
J Infect. 1991 Sep;23(2):179-82. doi: 10.1016/0163-4453(91)92190-g.

由戊糖片球菌引起的尿路感染继发的脓毒性休克

Septic Shock Secondary to a Urinary Tract Infection with Pediococcus Pentosaceus.

作者信息

Han Amneet, Mehta Jeet, Pauly Rebecca R

出版信息

Mo Med. 2016 May-Jun;113(3):179-81.

PMID:27443041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6140043/
Abstract

We present a case of a urinary tract infection secondary to Pediococcus pentosaceus causing septic shock and acute kidney injury in a 70-year-old male. We demonstrate successful treatment with a 10-day course of piperacillin/tazobactam. Recently, Pediococci have been found to be the cause of opportunistic infections in humans. This has posed a challenge to treating infections caused by this species because it has been found to be resistant to multiple antibiotics, including glycopeptides.

摘要

我们报告一例70岁男性因戊糖片球菌引起泌尿道感染继发感染性休克和急性肾损伤的病例。我们展示了使用哌拉西林/他唑巴坦治疗10天疗程取得成功的案例。最近，已发现片球菌是人类机会性感染的病因。这给治疗该菌种引起的感染带来了挑战，因为已发现它对包括糖肽类在内的多种抗生素具有耐药性。